Peptone: finding opportunity in disorder
Combining experimental and computational tools, Peptone is targeting disordered regions of proteins previously thought to be undruggable.
SAN FRANCISCO--(BUSINESS WIRE)--ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tests, announces new data that will be presented at the European Society for Medical Oncology’s (ESMO) Congress Oct. 20-24.
Read the full article here: https://www.nature.com/articles/d41587-023-00011-x